ORIC Pharmaceuticals Inc. (ORIC) NASDAQ

$3.68 -0.19 (-4.91%)

Market Cap: $145.28M

As of 05/18/22 04:00 PM EDT. Market closed.

(ORIC)

ORIC Pharmaceuticals Inc. (ORIC) NASDAQ

$3.68 -0.19 (-4.91%)

Market Cap: $145.28M

As of 05/18/22 04:00 PM EDT. Market closed.

ORIC Pharmaceuticalsis a clinical stage biopharmaceutical company dedicated to improving patients' lives by Overcoming Resistance In Cancer. ORIC's lead product candidate, ORIC-101, is a potent and selective small molecule antagonist of the glucocorticoid receptor, which has been linked to resistance to multiple classes of cancer therapeutics across a variety of solid tumors. ORIC-101 is ... read more

ORIC Pharmaceuticalsis a clinical stage biopharmaceutical company dedicated to improving patients' lives by Overcoming Resistance In Cancer. ORIC's lead product candidate, ORIC-101, is a potent and selective small molecule antagonist of the glucocorticoid receptor, which has been linked to resistance to multiple classes of cancer therapeutics across a variety of solid tumors. ORIC-101 is currently in two separate Phase 1b trials in combination with (1) Abraxane (nab-paclitaxel) in advanced or metastatic solid tumors and (2) Xtandi (enzalutamide) in metastatic prostate cancer. ORIC's other product candidates include (1) ORIC-533, an orally bioavailable small molecule inhibitor of CD73, a key node in the adenosine pathway believed to play a central role in resistance to chemotherapy- and immunotherapy-based treatment regimens, (2) ORIC-944, an allosteric inhibitor of the polycomb repressive complex 2 (PRC2) via the EED subunit, being developed for prostate cancer, and (3) ORIC-114, a brain penetrant inhibitor designed to selectively target EGFR and HER2 with high potency against exon 20 insertion mutations, being developed across multiple genetically defined cancers. Beyond these four product candidates, ORIC is also developing multiple precision medicines targeting other hallmark cancer resistance mechanisms. ORIC has offices in South San Francisco and San Diego, California. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Jacob Chacko
Full Time Employees
61
URL
Address
240 E. Grand Ave., 2Nd Floor, California, South San Francisco, 94080.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Jacob Chacko
Full Time Employees
61
Address
240 E. Grand Ave., 2Nd Floor, California, South San Francisco, 94080.
PRICE CHART
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
KEY STATS
Open
$0
Previous Close
$3.87
Days Range
$3.39 - $3.87
52 week range
$2.62 - $26.70
Volume
422,530
Avg. Volume (30 days)
506,237
Market Cap
$145.28M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
39,478,212
Open
$0
Previous Close
$3.87
Days Range
$3.39 - $3.87
52 week range
$2.62 - $26.70
Volume
422,530
Avg. Volume (30 days)
506,237
Market Cap
$145.28M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
39,478,212

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR ORIC PHARMACEUTICALS INC
Owner Relationship Date Transaction Cost # Shares Value($) Total Shares Form 4
Chacko Jacob President and CEO May 13, 2022 Buy $2.82 76,072 214,561 802,652 May 13, 2022, 06:52 PM
Chacko Jacob President and CEO May 12, 2022 Buy $2.75 69,354 190,467 726,580 May 13, 2022, 06:52 PM
Chacko Jacob President and CEO May 11, 2022 Buy $2.90 304,574 883,569 657,226 May 13, 2022, 06:52 PM
Piscitelli Dominic Chief Financial Officer Mar 31, 2022 Buy $5.36 60,000 321,624 60,000 Mar 31, 2022, 08:51 PM
Chacko Jacob President and CEO Mar 25, 2022 Buy $4.54 50,000 227,170 352,652 Mar 25, 2022, 06:42 PM
Chacko Jacob President and CEO Mar 24, 2022 Buy $5.03 42,873 215,660 302,652 Mar 25, 2022, 06:42 PM
Chacko Jacob President and CEO Mar 23, 2022 Buy $4.98 257,127 1,280,878 259,779 Mar 25, 2022, 06:42 PM
COLUMN GROUP II, LP 10% Owner Nov 12, 2021 Option Exercise $16.00 16,625 266,000 16,625 Nov 16, 2021, 04:49 PM
Heyman Richard A. Director Sep 14, 2021 Sale $25.05 706 17,686 216,954 Sep 16, 2021, 06:19 PM
Heyman Richard A. Director Sep 15, 2021 Sale $25.03 682 17,074 216,272 Sep 16, 2021, 06:19 PM
Chacko Jacob President and CEO Sep 15, 2021 Sale $25.06 3,736 93,629 2,652 Sep 16, 2021, 06:17 PM
Chacko Jacob President and CEO Sep 14, 2021 Sale $25.05 4,420 110,706 6,388 Sep 16, 2021, 06:17 PM
Heyman Richard A. Director Sep 13, 2021 Sale $25.01 601 15,033 217,660 Sep 14, 2021, 04:03 PM
Heyman Richard A. Director Sep 10, 2021 Sale $25.10 479 12,023 218,261 Sep 14, 2021, 04:03 PM
Chacko Jacob President and CEO Sep 10, 2021 Sale $25.08 2,942 73,783 13,609 Sep 14, 2021, 04:01 PM
Chacko Jacob President and CEO Sep 13, 2021 Sale $25.02 2,801 70,089 10,808 Sep 14, 2021, 04:01 PM
Heyman Richard A. Director Sep 07, 2021 Sale $25.11 1,086 27,272 218,740 Sep 09, 2021, 04:36 PM
Chacko Jacob President and CEO Sep 08, 2021 Sale $25.03 200 5,007 16,551 Sep 09, 2021, 04:33 PM
Chacko Jacob President and CEO Sep 07, 2021 Sale $25.11 5,981 150,173 16,751 Sep 09, 2021, 04:33 PM
SCHELLER RICHARD H Director May 21, 2021 Sale $25.19 1,231 31,008 39,192 May 24, 2021, 07:29 PM
SCHELLER RICHARD H Director May 20, 2021 Sale $25.08 659 16,528 40,423 May 24, 2021, 07:29 PM
SCHELLER RICHARD H Director May 24, 2021 Sale $25.00 100 2,500 39,092 May 24, 2021, 07:29 PM
Heyman Richard A. Director May 18, 2021 Sale $25.32 2,161 54,715 221,226 May 18, 2021, 08:22 PM
Heyman Richard A. Director May 17, 2021 Sale $25.07 498 12,484 223,387 May 18, 2021, 08:22 PM
Heyman Richard A. Director May 14, 2021 Sale $25.31 3,215 81,382 223,885 May 18, 2021, 08:22 PM
SCHELLER RICHARD H Director May 18, 2021 Sale $25.34 2,800 70,958 41,082 May 18, 2021, 08:20 PM
SCHELLER RICHARD H Director May 17, 2021 Sale $25.06 500 12,530 43,882 May 18, 2021, 08:20 PM
SCHELLER RICHARD H Director May 14, 2021 Sale $25.38 4,615 117,117 44,382 May 18, 2021, 08:20 PM
Heyman Richard A. Director Apr 30, 2021 Sale $25.26 100 2,526 227,200 Apr 30, 2021, 07:59 PM
Heyman Richard A. Director Apr 28, 2021 Sale $25.08 100 2,508 227,300 Apr 30, 2021, 07:59 PM
Heyman Richard A. Director Apr 01, 2021 Sale $25.00 100 2,500 227,400 Apr 05, 2021, 07:42 PM
Chacko Jacob President and CEO Apr 01, 2021 Sale $25.09 800 20,070 61,700 Apr 05, 2021, 07:40 PM
GORDON CARL L Director Mar 30, 2021 Sale $23.93 27,869 666,905 2,212,571 Mar 31, 2021, 05:11 PM
GORDON CARL L Director Mar 29, 2021 Sale $23.31 75,555 1,761,187 2,240,440 Mar 31, 2021, 05:11 PM
ORBIMED ADVISORS LLC Director Mar 30, 2021 Sale $23.93 27,869 666,905 2,212,571 Mar 31, 2021, 05:08 PM
ORBIMED ADVISORS LLC Director Mar 29, 2021 Sale $23.31 75,555 1,761,187 2,240,440 Mar 31, 2021, 05:08 PM
ORBIMED ADVISORS LLC Director Mar 26, 2021 Sale $23.88 27,816 664,246 2,315,995 Mar 26, 2021, 05:51 PM
ORBIMED ADVISORS LLC Director Mar 25, 2021 Sale $24.70 51,523 1,272,618 2,343,811 Mar 26, 2021, 05:51 PM
ORBIMED ADVISORS LLC Director Mar 24, 2021 Sale $24.80 32,959 817,383 2,395,334 Mar 26, 2021, 05:51 PM
GORDON CARL L Director Mar 24, 2021 Sale $24.80 32,959 817,383 2,395,334 Mar 26, 2021, 05:46 PM
GORDON CARL L Director Mar 26, 2021 Sale $23.88 27,816 664,246 2,315,995 Mar 26, 2021, 05:46 PM
GORDON CARL L Director Mar 25, 2021 Sale $24.70 51,523 1,272,618 2,343,811 Mar 26, 2021, 05:46 PM
GORDON CARL L Director Mar 23, 2021 Sale $24.32 3,992 97,085 2,428,293 Mar 23, 2021, 05:26 PM
GORDON CARL L Director Mar 22, 2021 Sale $26.47 7,673 203,104 2,432,285 Mar 23, 2021, 05:26 PM
GORDON CARL L Director Mar 19, 2021 Sale $26.47 21,275 563,149 2,439,958 Mar 23, 2021, 05:26 PM
ORBIMED ADVISORS LLC Director Mar 19, 2021 Sale $26.47 21,275 563,149 2,439,958 Mar 23, 2021, 05:22 PM
ORBIMED ADVISORS LLC Director Mar 23, 2021 Sale $24.32 3,992 97,085 2,428,293 Mar 23, 2021, 05:22 PM
ORBIMED ADVISORS LLC Director Mar 22, 2021 Sale $26.47 7,673 203,104 2,432,285 Mar 23, 2021, 05:22 PM
ORBIMED ADVISORS LLC Director Mar 18, 2021 Sale $28.03 6,059 169,834 2,461,233 Mar 18, 2021, 09:07 PM
ORBIMED ADVISORS LLC Director Mar 17, 2021 Sale $28.43 18,790 534,200 2,467,292 Mar 18, 2021, 09:07 PM
ORBIMED ADVISORS LLC Director Mar 16, 2021 Sale $27.72 41,353 1,146,305 2,486,082 Mar 18, 2021, 09:07 PM
GORDON CARL L Director Mar 17, 2021 Sale $28.43 18,790 534,200 2,467,292 Mar 18, 2021, 09:04 PM
GORDON CARL L Director Mar 16, 2021 Sale $27.72 41,353 1,146,305 2,486,082 Mar 18, 2021, 09:04 PM
GORDON CARL L Director Mar 18, 2021 Sale $28.03 6,059 169,834 2,461,233 Mar 18, 2021, 09:04 PM
ORBIMED ADVISORS LLC Director Mar 15, 2021 Sale $29.14 89,210 2,599,579 2,527,435 Mar 15, 2021, 08:55 PM
ORBIMED ADVISORS LLC Director Mar 12, 2021 Sale $30.29 90,521 2,741,881 2,616,645 Mar 15, 2021, 08:55 PM
ORBIMED ADVISORS LLC Director Mar 11, 2021 Sale $33.04 58,551 1,934,525 2,707,166 Mar 15, 2021, 08:55 PM
GORDON CARL L Director Mar 15, 2021 Sale $29.14 89,210 2,599,579 2,527,435 Mar 15, 2021, 08:50 PM
GORDON CARL L Director Mar 12, 2021 Sale $30.29 90,521 2,741,881 2,616,645 Mar 15, 2021, 08:50 PM
GORDON CARL L Director Mar 11, 2021 Sale $33.04 58,551 1,934,525 2,707,166 Mar 15, 2021, 08:50 PM
ORBIMED ADVISORS LLC Director Apr 24, 2020 Buy $16.00 281,250 4,500,000 281,250 Apr 28, 2020, 05:13 PM
GORDON CARL L Director Apr 24, 2020 Buy $16.00 281,250 4,500,000 281,250 Apr 28, 2020, 05:07 PM
Load More Insider Transactions
Buy Sale Option Exercise
Owner Relationship Date Value($)
Chacko Jacob President and CEO 05/13/2022 214,561
Chacko Jacob President and CEO 05/12/2022 190,467
Chacko Jacob President and CEO 05/11/2022 883,569
Piscitelli Dominic Chief Financial Officer 03/31/2022 321,624
Chacko Jacob President and CEO 03/25/2022 227,170
Chacko Jacob President and CEO 03/24/2022 215,660
Chacko Jacob President and CEO 03/23/2022 1,280,878
COLUMN GROUP II, LP 10% Owner 11/12/2021 266,000
Heyman Richard A. Director 09/14/2021 17,686
Heyman Richard A. Director 09/15/2021 17,074
Chacko Jacob President and CEO 09/15/2021 93,629
Chacko Jacob President and CEO 09/14/2021 110,706
Heyman Richard A. Director 09/13/2021 15,033
Heyman Richard A. Director 09/10/2021 12,023
Chacko Jacob President and CEO 09/10/2021 73,783
Chacko Jacob President and CEO 09/13/2021 70,089
Heyman Richard A. Director 09/07/2021 27,272
Chacko Jacob President and CEO 09/08/2021 5,007
Chacko Jacob President and CEO 09/07/2021 150,173
SCHELLER RICHARD H Director 05/21/2021 31,008
SCHELLER RICHARD H Director 05/20/2021 16,528
SCHELLER RICHARD H Director 05/24/2021 2,500
Heyman Richard A. Director 05/18/2021 54,715
Heyman Richard A. Director 05/17/2021 12,484
Heyman Richard A. Director 05/14/2021 81,382
SCHELLER RICHARD H Director 05/18/2021 70,958
SCHELLER RICHARD H Director 05/17/2021 12,530
SCHELLER RICHARD H Director 05/14/2021 117,117
Heyman Richard A. Director 04/30/2021 2,526
Heyman Richard A. Director 04/28/2021 2,508
Heyman Richard A. Director 04/01/2021 2,500
Chacko Jacob President and CEO 04/01/2021 20,070
GORDON CARL L Director 03/30/2021 666,905
GORDON CARL L Director 03/29/2021 1,761,187
ORBIMED ADVISORS LLC Director 03/30/2021 666,905
ORBIMED ADVISORS LLC Director 03/29/2021 1,761,187
ORBIMED ADVISORS LLC Director 03/26/2021 664,246
ORBIMED ADVISORS LLC Director 03/25/2021 1,272,618
ORBIMED ADVISORS LLC Director 03/24/2021 817,383
GORDON CARL L Director 03/24/2021 817,383
GORDON CARL L Director 03/26/2021 664,246
GORDON CARL L Director 03/25/2021 1,272,618
GORDON CARL L Director 03/23/2021 97,085
GORDON CARL L Director 03/22/2021 203,104
GORDON CARL L Director 03/19/2021 563,149
ORBIMED ADVISORS LLC Director 03/19/2021 563,149
ORBIMED ADVISORS LLC Director 03/23/2021 97,085
ORBIMED ADVISORS LLC Director 03/22/2021 203,104
ORBIMED ADVISORS LLC Director 03/18/2021 169,834
ORBIMED ADVISORS LLC Director 03/17/2021 534,200
ORBIMED ADVISORS LLC Director 03/16/2021 1,146,305
GORDON CARL L Director 03/17/2021 534,200
GORDON CARL L Director 03/16/2021 1,146,305
GORDON CARL L Director 03/18/2021 169,834
ORBIMED ADVISORS LLC Director 03/15/2021 2,599,579
ORBIMED ADVISORS LLC Director 03/12/2021 2,741,881
ORBIMED ADVISORS LLC Director 03/11/2021 1,934,525
GORDON CARL L Director 03/15/2021 2,599,579
GORDON CARL L Director 03/12/2021 2,741,881
GORDON CARL L Director 03/11/2021 1,934,525
ORBIMED ADVISORS LLC Director 04/24/2020 4,500,000
GORDON CARL L Director 04/24/2020 4,500,000
Load More Insider Transactions
CHANGE IN SHARES OUTSTANDING
STOCK BUYBACKS
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
12/31/2021
06/30/2021
3.44%
2Q
12/31/2021
03/31/2021
3.47%
3Q

Period of Report: 12/31/2021

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
06/30/2021
3.44%
2Q
03/31/2021
3.47%
3Q